Pharmacopsychiatry 2006; 39(5): 192-193
DOI: 10.1055/s-2006-948330
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Association of Auditory Hallucinations and Anticonvulsant Hypersensitivity Syndrome with Carbamazepine Treatment

A Case ReportP. A. Beitinger 1 , T. Kirmeier 1 , T. Bronisch 1 , T. C. Wetter 1
  • 1Max Planck Institute of Psychiatry·Munich·Germany
Further Information

Publication History

Received 1.1.2006 Revised 22.5.2006

Accepted 6.6.2006

Publication Date:
30 August 2006 (online)

Carbamazepine is effective in the treatment of acute mania and in the prevention of episodes in bipolar disorder, and it may also be useful in depression, impulse-control disorder and withdrawal from alcohol and benzodiazepine dependence. A potentially life-threatening side effect is the anticonvulsant hypersensitivity syndrome. Here, we describe a patient who developed severe auditory hallucinations followed by a distinct hypersensitivity syndrome most likely induced by carbamazepine treatment.

References

  • 1 Benatar M, Sahin M, Davis R. Antiepileptic drug-induced visual hallucinations in a child.  Pediatr Neurol. 2000;  23 439-441
  • 2 Berger H. An unusual manifestation of Tegretol (carbamazepine) toxicity.  Ann Intern Med. 1971;  74 449-450
  • 3 Dalby MA. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy.  Epilepsia. 1971;  12 325-334
  • 4 Degner D, Kropp S, Porzig J, Grohmann R, Ruther E. Pseudohallucinations associated with moclobemide: a case report.  Pharmacopsychiatry. 2005;  38 179-181
  • 5 Franks RD, Richter AJ. Schizophrenia-like psychosis associated with anticonvulsant toxicity.  Am J Psychiatry. 1979;  136 973-974
  • 6 Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.  Drug Saf. 1999;  21 489-501
  • 7 Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.  J Gen Intern Med. 2002;  17 349-355
  • 8 Mckee RJW, Larkin JG, Brodie MJ. Acute psychosis with carbamazepine and sodium valproate.  Lancet. 1989;  333 167
  • 9 Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Antidepressant effects of carbamazepine.  Am J Psychiatry. 1986;  143 29-34
  • 10 Prueter C, Waberski TD, Norra C, Podoll K. Palinacousis leading to the diagnosis of temporal lobe seizures in a patient with schizophrenia.  Seizure. 2002;  11 198-200
  • 11 Schweizer E, Rickels K, Case WG, Greenblatt DJ. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.  Arch Gen Psychiatry. 1991;  48 448-452
  • 12 Stewart B, Brennan DM. Auditory hallucinations after right temporal gyri resection.  J Neuropsychiatry Clin Neurosci. 2005;  17 243-245
  • 13 Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L. et al . Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.  Am J Psychiatry. 1998;  155 54-61
  • 14 Weaver DF, Camfield P, Fraser A. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes.  Neurology. 1988;  38 755-759

Correspondence

P. A. Beitinger

Max Planck Institute of Psychiatry

Kraepelinstr. 2-10·80804 Munich·Germany

Phone: +49/89/30 62 24 04

Fax: +49/89/30 62 25 50

Email: beitinger@mpipsykl.mpg.de

    >